Organic Growth Collapses to 4% From 15% as Ryan Specialty Trims Margin Outlook
RYAN sits 48% above its 52-week low of $29.28.
Summary
Ryan Specialty's organic revenue growth decelerated to 4.0% in Q3 from 15.0% a year ago — the sharpest slowdown in recent memory and the number that matters most for a broker valued on growth. Total revenue rose 4.7% to $790.0 million and adjusted diluted EPS came in at $0.51 versus $0.47, but adjusted EBITDAC margin slipped to 30.9% from 31.2% as compensation costs rose faster than revenue. Management is now guiding full-year 2026 Adjusted EBITDAC margin down modestly versus last year, while keeping organic growth in the mid-single digits — a cut to the margin line. The company returned $173.7 million to shareholders in the quarter, including $150.0 million of buybacks, and declared a $0.13 quarterly dividend payable November 24. The 4.0% organic print against a 15.0% prior-year comparison is the crux: the market has been paying up for a compounder, and this quarter shows the cycle biting.
At the time of this announcement, RYAN was trading at $43.28 on NYSE in the Finance sector, with a market capitalization of approximately $11.1B. The 52-week trading range was $29.28 to $58.94. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: BusinessWire.